Thirty-six medication-nave children 9-14 years of age , diagnosed with ADHD , were enrolled for 6 weeks in a crossover trial , with 2 weeks of methylphenidate , dextroamphetamine , and a placebo in a randomly assigned , counterbalanced sequence .